Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioMedWire Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1275894206469267456.png) BioMedWire [@BioMedWire](/creator/twitter/BioMedWire) on x 1296 followers
Created: 2025-07-15 14:00:38 UTC

$MRK begins clinical trials for MK-8527, a once-monthly oral HIV PrEP candidate—potential step forward in long-acting HIV prevention:

#Merck #HIVPrevention #PrEP #ClinicalTrials #HealthcareInnovation


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945121330950553629/c:line.svg)

**Related Topics**
[$mrk](/topic/$mrk)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BioMedWire/status/1945121330950553629)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BioMedWire Avatar BioMedWire @BioMedWire on x 1296 followers Created: 2025-07-15 14:00:38 UTC

$MRK begins clinical trials for MK-8527, a once-monthly oral HIV PrEP candidate—potential step forward in long-acting HIV prevention:

#Merck #HIVPrevention #PrEP #ClinicalTrials #HealthcareInnovation

XX engagements

Engagements Line Chart

Related Topics $mrk stocks healthcare

Post Link

post/tweet::1945121330950553629
/post/tweet::1945121330950553629